Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP9 | P14780 | 1/20 | 0.67 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.43 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.43 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.43 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Aprobarbital SCHEMBL21807710 | 0.98 | MMP9 (0.65) | MMP9CYP3A4NR1I2KDM4EALDH1A1 | |
| Talbutal SCHEMBL4263344 | 0.90 | MMP9 (0.69) | MMP9CYP3A4NR1I2KDM4EALDH1A1 | |
| SCHEMBL10582779 | 0.86 | MMP9 (0.51) | MMP9CYP3A4NR1I2KDM4EALDH1A1 | |
| Aprobarbital SCHEMBL15543386 | 0.84 | MMP9 (0.51) | MMP9CYP3A4NR1I2KDM4EALDH1A1 | |
| Talbutal SCHEMBL122147 | 0.83 | MMP9 (0.76) | MMP9CYP3A4NR1I2KDM4EALDH1A1 | |
| Secobarbital SCHEMBL80734 | 0.80 | MMP9 (1.00) | MMP9CYP3A4NR1I2KDM4EALDH1A1 | |
| Secobarbital SCHEMBL41181 | 0.80 | MMP9 (1.00) | MMP9CYP3A4NR1I2KDM4EALDH1A1 | |
| Secobarbital SCHEMBL80735 | 0.80 | MMP9 (1.00) | MMP9CYP3A4NR1I2KDM4EALDH1A1 | |
| Secobarbital SCHEMBL8085730 | 0.80 | MMP9 (1.00) | MMP9CYP3A4NR1I2KDM4EALDH1A1 | |
| Secobarbital SCHEMBL41182 | 0.79 | MMP9 (0.97) | MMP9CYP3A4NR1I2KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4994 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3441087-B1 | METHODS OF TREATING CHRONIC PAIN | TEVA PHARMACEUTICALS INT GMBH (CH) | 2025-02-19 | — | — | EP | claimed |
| US-12161695-B2 | GABA A receptor agonists for treatment of disorders influenced by dysfunction BETA cells | DIAMYD MEDICAL AB (SE) | 2024-12-10 | — | — | US | claimed |
| CN-114572330-B | Electric vehicle intelligent vehicle-mounted terminal based on millimeter wave radar | 深圳飞亮智能科技有限公司 | 2024-03-08 | — | — | CN | claimed |
| US-11839615-B2 | Compounds and methods for treating addiction and related disorders | ASTROCYTE PHARMACEUTICALS, INC. (US) | 2023-12-12 | — | — | US | claimed |
| CN-116151848-B | Gas cylinder quality safety traceability system based on Internet of things | 深圳市普燃计算机软件科技有限公司 | 2023-08-11 | — | — | CN | claimed |
| CN-115457702-B | New energy automobile fills electric pile based on cloud calculates | 湖北盛泓电力技术开发有限公司 | 2023-04-21 | — | — | CN | claimed |
| EP-3891505-B1 | A METHOD FOR MEASURING A CONCENTRATION OF A BIOMARKER/ANALYTE IN BLOOD FROM MAMMALS | REDHOTDIAGNOSTICS AB (SE) | 2022-11-30 | — | — | EP | claimed |
| CN-109903284-B | HER2 immunohistochemical image automatic discrimination method and system | 武汉大学 | 2022-07-05 | — | — | CN | claimed |
| US-20220187304-A1 | A Method for Measuring a Concentration of a Biomarker-Analyte In Blood from Mammals | REDHOT DIAGNOSTICS AB (SE) | 2022-06-16 | — | — | US | claimed |
| CN-114572330-A | Electric motor car intelligence vehicle mounted terminal based on millimeter wave radar | 深圳飞亮智能科技有限公司 | 2022-06-03 | — | — | CN | claimed |
| WO-2000048636-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2000-08-24 | — | — | WO | claimed |
| EP-0983060-A1 | SOLID POROUS MATRICES AND METHODS OF MAKING AND USING THE SAME | IMARX PHARMACEUTICAL CORP. (US) | 2000-03-08 | — | — | EP | claimed |
| WO-2000001805-A1 | CELLS AND ANIMALS DEFICIENT IN PROTEIN KINASE C EPSILON | MESSING ROBERT O (US) | 2000-01-13 | — | — | WO | claimed |
| WO-1999042111-A1 | HIGH-ENERGY CYCLODEXTRIN COMPLEXES | CYCLOPS, EHF. (IS) | 1999-08-26 | — | — | WO | claimed |
| WO-1998051282-A1 | SOLID POROUS MATRICES AND METHODS OF MAKING AND USING THE SAME | IMARX PHARMACEUTICAL CORP. (US) | 1998-11-19 | — | — | WO | claimed |
| US-5770222-A | Therapeutic drug delivery systems | IMARX PHARMACEUTICAL CORP. (US) | 1998-06-23 | — | — | US | claimed |
| US-5585243-A | SEPARATELY INCUBATING HUMAN PLATELETS WITH BLOOD SAMPLE ANDREAGENT DRUG SOLUTION TO FORM COMPLEXES, DETERMINING AMOUNT OF BOUND ANTIBODY | THE BLOOD CENTER OF SOUTHEASTERN WISCONSIN, INC. (US) | 1996-12-17 | — | — | US | claimed |
| WO-1995008116-A1 | METHOD OF DETECTING CYTOPENIA THAT IS MEDIATED BY DRUG-DEPENDENT ANTIBODY BINDING TO BLOOD CELLS | THE BLOOD CENTER OF SOUTHEASTERN WISCONSIN, INC. (US) | 1995-03-23 | — | — | WO | claimed |
| US-4557934-A | ALONG WITH A DIOL PYRROLIDONE OR AN AZACYCLOPENTAN-2-ONE | THE PROCTER & GAMBLE COMPANY (US) | 1985-12-10 | — | — | US | claimed |
| US-RE29875-E | THEOPHYLLINE SOLUBILIZED BY GLYCERYL GUAIACOLATE, POTASSIUM GUAIACOL SULFONATE OR GUAIACOL | MEAD JOHNSON & COMPANY (US) | 1979-01-02 | — | — | US | claimed |